Eldecalcitol for GLucocorticoid induced OsteopoRosIs versus Alfacalcidol
Phase of Trial: Phase IV
Latest Information Update: 07 Feb 2018
At a glance
- Drugs Eldecalcitol (Primary) ; Alfacalcidol
- Indications Corticosteroid-induced osteoporosis
- Focus Therapeutic Use
- Acronyms e-GLORIA
- 10 Jun 2017 Biomarkers information updated
- 01 Apr 2016 Planned End Date changed from 28 Feb 2018 to 31 May 2019.
- 01 Apr 2016 Status changed from recruiting to active, no longer recruiting.